London Daily

Focus on the big picture.
Friday, Aug 01, 2025

Hong Kong Covid-19 panel backs Pfizer vaccine, seeks more Norway deaths details

Hong Kong Covid-19 panel backs Pfizer vaccine, seeks more Norway deaths details

Unanimous backing from experts will go before health secretary for final decision, paving way for mass inoculation drive from mid-February.

A government advisory panel has recommended the approval of the Pfizer-BioNTech Covid-19 vaccine for emergency use in Hong Kong, although it said a “circuit-breaking” mechanism could stop a mass inoculation campaign from being rolled out amid heightened concerns over serious side effects from the jab.

The panel of experts meeting on Monday took three hours to give their unanimous backing to the vaccine developed by the American pharmaceutical giant Pfizer and German company BioNTech, paving the way for the jabs scheme after Lunar New Year. The recommendation will now go before the health secretary for a final decision.

The 12-member Advisory Panel on Covid-19 Vaccines pored over thousands of pages of trial data and other material to offer their verdict on the efficacy and safety of the jab.

Its convenor, Professor Wallace Lau Chak-sing, said the panel decided to recommend use of the vaccine after concluding the benefits outweighed the risks, considering all the information provided.

“After discussing it thoroughly at the meeting, all 12 members of the panel have decided to recommend the approval of the use of the vaccine,” Lau told a press conference.

Phase three trials showed the vaccine achieved an efficacy rate of about 95 per cent for recipients over the age of 16, but recent reports of serious side effects had raised concerns.

Lau said the panel would seek more information from Fosun Pharmaceutical – the mainland China partner of BioNTech – and regulatory agencies in Norway, where at least 29 elderly recipients of the jab died.

“According to the information we have got, in Norway, up to 42,000 have actually received the vaccine,” Lau said, adding that of the 29 deaths, “13 have been suggested to be probably related to the vaccine”.

He said the panel still needed more data from Fosun on the causes of death of the 13.

“We understand they were all elderly, they all had multiple different medical conditions,” he said.

“We need to know whether their deaths were actually related to their underlying problems or to the vaccine.”

Citing Pfizer-BioNTech’s data, Lau said on average only 11.1 people per 1 million had a serious allergic reaction. He said more data would also be sought from Germany, where 10 people had died out of 800,000 recipients.

Addressing reports of recipients developing Bell’s palsy, a temporary facial paralysis, Lam said the condition could be treated with steroids.

Panel member Professor David Hui Shu-cheong added the condition usually affected one in every 100,000 people and just one country had reported a higher than normal rate post-inoculation.

Asked why the panel did not wait for extra data on mortality rates overseas, Lau said only that the experts would continue to look into side effects elsewhere.

Lau also did not detail the circumstances under which the panel would recommend the government halt use of the vaccines.

“I think it will be very difficult to say here what are the clear definitions [when we will recommend the Food and Health Bureau stop use of the vaccine],” he said.

“It really depends on the overall benefits of this vaccine to the population of Hong Kong and the possible side effects that we will encounter later on.”

The panel is made up of public health, infectious disease, immunology, drug regulation and clinical care experts.

Lau is a former president of the Hong Kong Academy of Medicine and chair of rheumatology and clinical immunology at the University of Hong Kong.


Hong Kong has also procured Beijing-based Sinovac’s vaccine.


Two infectious disease experts, Dr Leung Chi-chiu and Dr Joseph Tsang Kay-yan, who are not on the panel, agreed with the decision, saying it was needed to get the roll-out moving, as the remaining approval procedures could still take time.

Leung believed that if the panel had failed to reach a decision, Pfizer-BioNTech could have delayed the delivery of the vaccine, as the companies had already held up supplies to some European countries.

He added recent reports did not show significant side effects of the vaccine in younger recipients, so the government could still tweak the inoculation order and protect vulnerable elderly residents if necessary.

A government spokesman welcomed the panel’s recommendation, and said the secretary for food and health would reach her decision as soon as possible.

The Post reported last week that the Pfizer-BioNTech vaccine was the first to apply for an emergency roll-out in Hong Kong, submitting its application in early January.

Hong Kong has reached purchase agreements for three vaccines, procuring 7.5 million doses of each. Aside from the Pfizer-BioNTech jabs, supplied by Fosun Pharma, the city has also procured Beijing-based Sinovac’s vaccine and one jointly developed by British-Swedish pharmaceutical firm AstraZeneca and Oxford University.

The city aims to roll out the inoculation programme after the Lunar New Year holiday in mid-February, with priority given to high-risk groups such as the elderly and health care workers.

Originally, Sinovac’s doses were expected to arrive in the city this month, followed by Pfizer-BioNTech shots in the first quarter and the AstraZeneca vaccine in the middle of the year.

Newsletter

Related Articles

0:00
0:00
Close
JD.com Launches €2.2 Billion Bid for German Electronics Retailer Ceconomy
Azerbaijan Proceeds with Plan to Legalise Casinos on Artificial Islands
Former Judge Charged After Drunk Driving Crash Kills Comedian in Brazil
Jeff Bezos hasn’t paid a dollar in taxes for decades. He makes billions and pays $0 in taxes, LEGALLY
China Increases Use of Exit Bans Amid Rising U.S. Tensions
IMF Upgrades Global Growth Forecast as Weaker Dollar Supports Outlook
Procter & Gamble to Raise U.S. Prices to Offset One‑Billion‑Dollar Tariff Cost
House Republicans Move to Defund OECD Over Global Tax Dispute
Botswana Seeks Controlling Stake in De Beers as Anglo American Prepares Exit
Trump Administration Proposes Repeal of Obama‑Era Endangerment Finding, Dismantling Regulatory Basis for CO₂ Emissions Limits
France Opens Criminal Investigation into X Over Algorithm Manipulation Allegations
A family has been arrested in the UK for displaying the British flag
Mel Gibson refuses to work with Robert De Niro, saying, "Keep that woke clown away from me."
Trump Steamrolls EU in Landmark Trade Win: US–EU Trade Deal Imposes 15% Tariff on European Imports
ChatGPT CEO Sam Altman says people share personal info with ChatGPT but don’t know chats can be used as court evidence in legal cases.
The British propaganda channel BBC News lies again.
Deputy attorney general's second day of meeting with Ghislaine Maxwell has concluded
Controversial March in Switzerland Features Men Dressed in Nazi Uniforms
Politics is a good business: Barack Obama’s Reported Net Worth Growth, 1990–2025
Thai Civilian Death Toll Rises to 12 in Cambodian Cross-Border Attacks
TSUNAMI: Trump Just Crossed the Rubicon—And There’s No Turning Back
Over 120 Criminal Cases Dismissed in Boston Amid Public Defender Shortage
UN's Top Court Declares Environmental Protection a Legal Obligation Under International Law
"Crazy Thing": OpenAI's Sam Altman Warns Of AI Voice Fraud Crisis In Banking
The Podcaster Who Accidentally Revealed He Earns Over $10 Million a Year
Trump Announces $550 Billion Japanese Investment and New Trade Agreements with Indonesia and the Philippines
US Treasury Secretary Calls for Institutional Review of Federal Reserve Amid AI‑Driven Growth Expectations
UK Government Considers Dropping Demand for Apple Encryption Backdoor
Severe Flooding in South Korea Claims Lives Amid Ongoing Rescue Operations
Japanese Man Discovers Family Connection Through DNA Testing After Decades of Separation
Russia Signals Openness to Ukraine Peace Talks Amid Escalating Drone Warfare
Switzerland Implements Ban on Mammography Screening
Japanese Prime Minister Vows to Stay After Coalition Loses Upper House Majority
Pogacar Extends Dominance with Stage Fifteen Triumph at Tour de France
CEO Resigns Amid Controversy Over Relationship with HR Executive
Man Dies After Being Pulled Into MRI Machine Due to Metal Chain in New York Clinic
NVIDIA Achieves $4 Trillion Valuation Amid AI Demand
US Revokes Visas of Brazilian Corrupted Judges Amid Fake Bolsonaro Investigation
U.S. Congress Approves Rescissions Act Cutting Federal Funding for NPR and PBS
North Korea Restricts Foreign Tourist Access to New Seaside Resort
Brazil's Supreme Court Imposes Radical Restrictions on Former President Bolsonaro
Centrist Criticism of von der Leyen Resurfaces as she Survives EU Confidence Vote
Judge Criticizes DOJ Over Secrecy in Dropping Charges Against Gang Leader
Apple Closes $16.5 Billion Tax Dispute With Ireland
Von der Leyen Faces Setback Over €2 Trillion EU Budget Proposal
UK and Germany Collaborate on Global Military Equipment Sales
Trump Plans Over 10% Tariffs on African and Caribbean Nations
Flying Taxi CEO Reclaims Billionaire Status After Stock Surge
Epstein Files Deepen Republican Party Divide
Zuckerberg Faces $8 Billion Privacy Lawsuit From Meta Shareholders
×